Michael Miller | Rx Communications, IR |
Paul Hickey | President and CEO |
Tom Stankovich | CFO |
Christine Ren-Fielding | Member, ReShape Scientific Advisory Board |
Anthony Vendetti | Maxim |
Good afternoon, and thank you for joining the ReShape Lifesciences Second Quarter 2023 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications.
Good afternoon, and thank you for joining the ReShape Lifesciences second quarter 2023 earnings call. I'm pleased to be joined today by Paul Hickey, President and Chief Executive Officer; and Tom Stankovich, Chief Financial Officer. Paul will provide an overview and update on the company's activities, which will include a discussion with Dr.